Long-term effects of smoking and smoking cessation on exercise stress testing: Three-year outcomes from a randomized clinical trial

Abstract

Background The long-term effects of smoking and smoking cessation on markers of cardiovascular disease (CVD) prognosis obtained during treadmill stress testing (TST) are unknown. The purpose of this study was to evaluate the long-term effects of smoking cessation and continued smoking on TST parameters that predict CVD risk. Methods In a prospective, double-blind, randomized, placebo-controlled trial of 5 smoking cessation pharmacotherapies, symptom-limited TST was performed to determine peak METs, rate-pressure product (RPP), heart rate (HR) increase, HR reserve, and 60-second HR recovery, before and 3 years after the target smoking cessation date. Relationships between TST parameters and treatments among successful abstainers and continuing smokers were evaluated using multivariable analyses. Results At baseline, the 600 current smokers (61% women) had a mean age of 43.4 (SD 11.5) years and smoked 20.7 (8.4) cigarettes per day. Their exercise capacity was 8.7 (2.3) METs, HR reserve was 86.6 (9.6)%, HR increase was 81.1 (20.9) beats/min, and HR recovery was 22.3 (11.3) beats. Cigarettes per day and pack-years were independently and inversely associated with baseline peak METs (P < .001), RPP (P < .01, pack-years only), HR increase (P < .05), and HR reserve (P < .01). After 3 years, 168 (28%) had quit smoking. Abstainers had greater improvements than continuing smokers (all P < .001) in RPP (2,055 mm Hg beats/min), HR increase (5.9 beats/min), and HR reserve (3.7%), even after statistical adjustment (all P < .001). Conclusions Smokers with a higher smoking burden have lower exercise capacity, lower HR reserve, and a blunted exercise HR response. After 3 years, TST improvements suggestive of improved CVD prognosis were observed among successful abstainers.

Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks

“…Participants were recruited via two different sources: 1) by contacting participants in an ongoing longitudinal study of smokers, the Wisconsin Smokers Health Study (WSHS 8,14,15 ), and 2) via media and community outreach. See Figure 1 for CONSORT diagram for both Cohort 1 (the WSHS) and Cohort 2 (community recruits).…”

The association of tobacco use and gender to cardiac rehabilitation outcomes: a preliminary investigation

“…The analyses demonstrate that fewer current and former tobacco users reached an important goal, Maximal Exercise Capacity. Greater daily smoking is associated with lower exercise capacity in current smokers and adults who quit smoking show greater improvements in exercise capacity than adults who continue to smoke (Asthana et al, 2012). Further, smoking is the most important risk factor in chronic obstructive pulmonary disease (COPD) (Eisner et al, 2010; Løkke et al, 2006) and COPD can impact exercise capacity.…”

Therapeutic Options: Lifestyle Measures and Pharmacological Approaches

“…Smokers commonly gain weight initially after smoking cessation; an increased BMI is a risk factor for cardiovascular disease itself. Despite this, ex-smokers perform better on an exercise stress test than current smokers, indicating that the positive health and fi tness benefi ts of quitting smoking outweigh the negative health effects of an increased BMI [ 6 ].…”